[Incidence of mycotic vaginitis in women using oral contraceptives].

2 groups of women who regularly visited the outpatient Clinic I of Obstetrics and Gynecology of the Academy of Medicines Institute of Gynecology and Obstetrics in Warsaw were observed in order to determine the incidence of mycotic vaginitis in women using oral contraceptives. The 1st group consisted of 222 patients users of oral contraceptives for 3 months to 2 years. The 2nd group comprised of 280 non-users was the control group. The ages in both groups ranged from 21 to 42 years. Smear results showed that 20.3% women in the 1st group had mycotic vaginitis compared with 23.1% in the control group. None of the women in the entire sample were diabetic. Catterall suggests that since progestogens cause an increase of glycogen stored in the vaginal mucous membrane patients using oral contraceptives may be more predisposed to develop mycotic vaginitis. Gershberg Wynn and Doar maintain that oral contraceptives definitely influence glucose tolerance. They question wherher indirectly contraceptives might harm the metabolism of carbohydrates. No significant difference in the blood sugar level of women using oral contraceptives as compared to that of non-users hgas been proven. Based on their particular sample the authors conclude that oral contraceptives have no significant effect on the incidence of mycotic vaginitis. (Summaries in RUS ENG).